Chemo before surgery may boost bladder cancer outcomes
NCT ID NCT07492225
First seen Mar 28, 2026 · Last updated Apr 25, 2026 · Updated 3 times
Summary
This study compares two treatments for people with high-risk upper tract urothelial cancer (a type of urinary tract cancer). One group gets chemotherapy (gemcitabine and cisplatin) before surgery to remove the kidney and ureter, while the other group has surgery alone. The goal is to see if chemo shrinks the tumor more before surgery and improves survival. The trial involves 120 adults who are healthy enough for chemo and surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UPPER URINARY TRACT UROTHELIAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Changhai Hospital
Shanghai, Shanghai Municipality, 200090, China
Conditions
Explore the condition pages connected to this study.